The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of anti-EGFR monoclonal antibody in EGFR FISH positive NSCLC patients: A meta-analysis of phase III randomized controlled trials.
 
Nikita Patel
No Relationships to Disclose
 
Madhusmita Behera
No Relationships to Disclose
 
Rathi Narayana Pillai
No Relationships to Disclose
 
Taofeek Kunle Owonikoko
Consulting or Advisory Role - Bayer; Celgene; Genentech/Roche; Novartis
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Celgene (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Genetic predictor of chemotherapy sensitivity (Inst)
 
Suchita Pakkala
No Relationships to Disclose
 
Chandra Prakash Belani
No Relationships to Disclose
 
Fadlo Raja Khuri
No Relationships to Disclose
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer